Western Drugmakers Increasingly Looking Towards The East

BMI View: The introduction of government price erosion mechanisms will accelerate across Europe, a view that is driven by need for fiscal austerity and supported by the actions of numerous governments over the past six months. Combined with other downward pressures, such as patent expiries, we believe the increasingly difficult operating environments for companies in the region highlight the imperative to expand in emerging markets.

To read the full article, please choose one of the following options: